Abstract:Objective To research the antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the probable antioxidant mechanism.Methods The parental BCap37 cell screening was used to establish Bads 200 breast cancer resistant cell model,then the cells were treated by tetrandrine combined with paclitaxel for 24,48,and 72 hours,respectively.Bads 200 breast cancer resistant cells cultured by normal method and simple paclitaxel were selected as control group and simple drug group,respectively.MTT assay was used to detect proliferation activity of cells in the three groups.Flow-cytometry was used to analyze the proportions of cells during different phases in the three groups.RT-PCR was used to detect the expression levels of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS).Results The inhibiting effect of tetrandrine combined with paclitaxel on proliferation of Bads 200 breast cancer resistant cells was significant,showing a time-dependent manner.Compared with control group,the apoptotic rate of Bads 200 breast cancer resistant cells increased gradually after treated by tetrandrine combined with paclitaxel for 24,48,and 72 hours,respectively (P＜0.01).The proportions of Bads 200 breast cancer resistant cells at S stage and G2/M stage decreased gradually,and the proportion of Bads 200 breast cancer resistant cells at G0/G1 stage increased gradually (P＜ 0.01).Compared with control group,the expression level of iNOS in tetrandrine group decreased,while the expression levels of NO and eNOS increased.The results of RT-PCR were coincidence with the results of cell spectrophotometer method.Conclusion Tetrandrine can significantly inhibit proliferation of Bads 200 breast cancer resistant cells,the mechanism is correlated with antioxidant effect,up-regualtion of eNOS expression,and down-regulation of iNOS expression.

Effects of Tetrandrine on apoptosis and cell cycle of human choriocarcinoma BeWo cells

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Effect of RNA Interference Targeting Egr-1 Inhibite Tetrandrine-Induced Autophagy and Apoptosis of Pancreatic PaTu8988 Cells in Vitro

The Effects of Tetrandrine on Proliferation and Apoptosis of Hunman Ovarian Cancer Cell Line A2780

Study on the efficacy of Tetrandrine in inducing the apoptosis of neuroblastoma cells

Growth inhibition and apoptosis induction of tetrandrine in human thyroid cancer cells(B-CPAP)

Tetrandrine Induces Apoptosis in Gallbladder Carcinoma in Vitro.

Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells.

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

Qualitative and quantitative study on the apoptosis of cervical cancer cells treated by tetrandrine

Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines

Cytotoxicity of tetrandrine and its effect on human hepatoma cell line 7402 radiosensitivity

Tetrandrine Induces Programmed Cell Death in Human Oral Cancer CAL 27 Cells Through the Reactive Oxygen Species Production and Caspase-Dependent Pathways and Associated with Beclin-1-induced Cell Autophagy.

Effects of PolyphyllinⅡ in Growth Inhibition of Human Breast Cancer Cells

Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.

Antineoplastic effect of tetrandrine on primary cancer cells isolated from ascites

Effect of Tetrandrine Combined with Daunorubicin on Expressions of P21 and P-gp in K562/A02 Cells

Effect of Tetrandrine and Toremifene on the Reversion of Multidrug Resistance of K562/A02 Cell Line

Antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the antioxidant mechanism

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells